An Updated Retrospective Study on Clinical and Microbiological Profile, Management and Predictors of Poor Outcomes in Infectious Endophthalmitis

Authors

  • Joana da Silva Rocha Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal https://orcid.org/0000-0001-5656-417X
  • Ana Rita Viana Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Carla Teixeira Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Sofia Justo Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Catarina Francisco Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Alexandre Reis da Silva Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Rui Carvalho Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Bruna Vieira Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Tiago Maio Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal
  • Sara Pereira Ophthalmology Department, Hospital Pedro Hispano, Matosinhos, Portugal

DOI:

https://doi.org/10.48560/rspo.43682

Keywords:

Endophthalmitis/diagnosis, Endophthalmitis/etiology, Endophthalmitis/therapy

Abstract

INTRODUCTION: Infectious endophthalmitis is a rare but vision-threatening intraocular infection, with a global incidence ranging from 0.021%0.021% to 0.32%0.32%. The most frequent exogenous causes are intravitreal injections and cataract surgery, while endogenous cases account for 5%5% - 20%20%. Despite major advances in diagnosis and management, visual prognosis remains poor for many patients. This study updates a previous series from the same hospital, expanding the cohort and aiming to identify predictors of poor prognosis while evaluating the impact of protocol modifications introduced in recent years.

METHODS: A retrospective review was conducted of all patients diagnosed with infectious endophthalmitis between 2013 and 2025 at Pedro Hispano Hospital. Collected data included demographics, comorbidities, etiology, timing of presentation and treatment, microbiological isolates, and therapeutic approaches. Visual acuity (VA) was converted to the logarithm of the minimum angle of resolution (LogMAR) for statistical analysis.

RESULTS: Thirty-one patients were included (87.1%(87.1% exogenous, 12.9%12.9% endogenous endophthalmitis). The main causes were intravitreal injections (29%)(29%) and cataract surgery (19.4%)(19.4%). Mean symptom-to-admission time was 1.94±1.51.94±1.5 days. Most patients (90.3%)(90.3%) had ≥1≥1systemic comorbidity, most commonly hypertension (51.6%)(51.6%), dyslipidemia (45.2%)(45.2%), and diabetes (41.9%)(41.9%), and more comorbidities correlated with poorer final VA (q=0.418;p=0.033)(q=0.418;p=0.033). Median initial VA was 2.4 LogMAR (hand motion). Cultures were positive in 29%29%, with Staphylococcus epidermidis as the most frequent. Gram-negative infections were uncommon but led to severe outcomes. Vitrectomy (PPV) was performed in 80.6%80.6% of cases, significantly reducing complication rates (16.0%vs83.3%(16.0%vs83.3% p=0.001)p=0.001). Early PPV (≤48h)(≤48h) was associated with greater visual improvement compared with late PPV (>48h)(>48h) (ΔVA−1.58vs−0.55;p=0.002)(ΔVA−1.58vs−0.55;p=0.002)

CONCLUSION: This updated series confirms the predominance of exogenous endophthalmitis, particularly post-injection, and underscores the importance of early surgical intervention. Higher comorbidity burden and treatment delays were predictors of poor outcome, while early PPV significantly improved recovery and reduced complications. These findings support continuous refinement of preventive and therapeutic strategies to optimize prognosis in infectious endophthalmitis.

Downloads

Download data is not yet available.

References

Segretin Gutierrez EFE, Garcia MM, Bursztyn M, Defferrari MM, Ortiz-Basso T. Incidence of endophthalmitis post cataract surgery in a tertiary hospital of Buenos Aires. Medicina. 2022;82:851-5.

Viana AR, Teixeira C, Carvalho R, Vieira B, Maio T, Tenedorio P. Perfil Clinico e Resultados dos Doentes com Endoftalmite Submetidos a Vitrectomia Via Pars Plana: Estudo Retrospetivo de Dez Anos. Oftalmologia. 2024;48:126-32. doi: 10.48560/rspo.33271

Felix R, Almeida M, Cortinhal T, Raimundo M, Figueira J, First J. Anatomic and Functional Outcomes Following Treatment of Acute Endophthalmitis: 7 Year Experience of the Central Region of Portugal. Oftalmologia.2023;48:215-24. doi: 10.48560/rspo.33231

Rangel CM, Parra MM, Corrales MI, Garcia D, Sanchez-Ávila R, Varon CL, Villareal E, Villarreal D, Tello A, Galvis V. Endophthalmitis in ophthalmological referral centre in Colombia: aetiology and microbial resistance. Cesk Slov Oftalmol. 2022;78:160-73. doi: 10.31348/2022/19.

Wade CI, Whitescarver TD, Ashcroft CR, Hobbs SD, Purt B, Reddy AK, et al. Endophthalmitis: a bibliographic review. Int Ophthalmol. 2021;41:4151-61. doi: 10.1007/s10792-021-01967-y.

Panahi P, Mirzakouchaki-Borujeni N, Pourdakan O, Arevalo JF. Early Viretctomy for Endophthalmitis: Are EVS Guidelines Still Valid? Ophthalmic Res. 2023;66:1318-26. doi: 10.1159/000534650.

Feng HL, Robbins CB, Fekrat S. A Nine-Year Analysis of Practice Patterns, Microbiological Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis. Ophthalmol Retina. 2020;4:555-9. doi: 10.1016/j.oret.2020.03.009.

Honavar SG. Endophthalmitis - A risk not worth taking. Indian J Ophthalmol. 2022;70:355. doi: 10.4103/ijo.IJO_94_22.

Day AC, Donachie PHJ, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye. 2015;29:552-60. doi: 10.1038/eye.2015.3.

Almarzouki N, Alessa S, Raffa L. Clinical profile of patients with endophthalmitis: A 16-year retrospective, cross-sectional study at tertiary care hospital in Western Saudi Arabia. Niger J Clin Pract. 2021;24:1527-30. doi: 10.4103/njcp.njcp_514_20.

Negretti GS, Chan W, Pavesio C, Muqit MM. Viretctomy for endophthalmitis: 5-year study of outcomes and complications. BMJ Open Ophthalmol. 2020;5:e000423. doi: 10.1136/bmjophth-2019-000423.

Results of the Endophthalmitis Viretctomy Study A Randomized Trial of Immediate Viretctomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Endophthalmitis Viretctomy Study Group. Arch Ophthalmol. 1995;113:1479-96.

Cruz-Martins N, Rodrigues CF, Lugo Merly AN, Toledo LA, Requejo GA, Melendez A, et al. Risk Factors Leading to Enucleation or Evisceration in Infectious Endophthalmitis. J Clin Med. 2022;11:3145. doi: 10.3390/jcm11113145.

Downloads

Published

2026-07-11

How to Cite

da Silva Rocha, J., Viana, A. R., Teixeira, C., Justo, S., Francisco, C., Reis da Silva, A., … Pereira, S. (2026). An Updated Retrospective Study on Clinical and Microbiological Profile, Management and Predictors of Poor Outcomes in Infectious Endophthalmitis. Revista Sociedade Portuguesa De Oftalmologia. https://doi.org/10.48560/rspo.43682

Issue

Section

Original Article